SAS code for 3-period, partial-replicated crossover study [RSABE / ABEL]
We have two Test formulations (T1 and T2) and One single Reference formulation (R). We want to test for bioequivalence of each test formulation against the reference formulation i.e. T1 vs. R and T2 vs. R. The test drug is a candidate of "NTI" Please suggest me the whether we can analyze the study as per the SAS code (after adequately modifying the same) provided by the USFDA in Warfarin OGD guidance.
Regards
Sonu
Regards
Sonu
Complete thread:
- SAS code for 3-period, partial-replicated crossover studyscorp2011 2015-06-15 12:36 [RSABE / ABEL]
- SAS code for 3-period, partial-replicated crossover study d_labes 2015-06-15 13:24
- SAS code for 3-period, partial-replicated crossover study MGR 2015-06-15 13:34
- SAS code for 3-period, partial-replicated crossover study ElMaestro 2015-06-15 13:46
- Partial-replicated crossover study with 2 Tests d_labes 2015-06-15 14:50
- SAS code for 3-period, partial-replicated crossover study ElMaestro 2015-06-15 13:46
- SAS code for 3-period, partial-replicated crossover study MGR 2015-06-15 13:34
- SAS code for 3-period, partial-replicated crossover study d_labes 2015-06-15 13:24